Home › Funds › Andera Partners › AGMB

Andera Partners position in AGMB

AGOMAB THERAPEUTICS NV · Health Care

Andera Partners reported holding 1,538,702 shares of AGMB (AGOMAB THERAPEUTICS NV) in its Q3 2026 13F filing — a position valued at US$17.1M, representing 9.72% of its reported portfolio and ranking #4 among its reported holdings. Andera Partners has disclosed AGMB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.54M sh
Reported value held$17.08M
Portfolio Weight9.72%
First reportedQ1 2026
Last changeHold
Updated2026-10-17

Last updated: 2026-10-17 · Source: SEC EDGAR Form 13F-HR

How Andera Partners's AGMB position evolved

Andera Partners first disclosed a stake in AGMB in Q1 2026 at 1,538,702 shares (US$16.1M). The position peaked in Q2 2026 at 1,538,702 shares, worth US$20.0M. Across 3 filings, Andera Partners held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,538,702 shares valued at US$17.1M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.54M $16.14M New
Q2 2026 1.54M $19.97M Hold
Q3 2026 1.54M $17.08M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AGMB and 13F data

AGMB (AGOMAB THERAPEUTICS NV) is a Health Care company. 33 other funds we track also report a position in AGMB — the largest reported positions include EQT Fund Management S.a r.l. (US$66.7M), Sanofi (US$36.1M), Redmile Group, LLC (US$35.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AGMB

All AGMB fund holders →

FAQ

How long has Andera Partners held AGMB?

Andera Partners has disclosed AGMB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Andera Partners's current position in AGMB?

As of Q3 2026, Andera Partners holds 1.54M shares of AGMB (AGOMAB THERAPEUTICS NV), valued at $17.08M, representing 9.72% of its reported portfolio and ranking #4.

Has Andera Partners been buying or selling AGMB?

In the latest 13F filing (Q3 2026), Andera Partners held unchanged its position in AGMB. The position peaked in Q2 2026 at 1.54M shares.

Which other funds hold AGMB?

Other major institutional holders of AGMB include EQT Fund Management S.a r.l., Sanofi, Redmile Group, LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.